MUMBAI, India, July 30 -- Intellectual Property India has published a patent application (202531076357 A) filed by Indian Institute Of Technology Kharagpur on August 11, 2025, for Unilamellar Liposomal Formulation Of Norclomipramine For Treatment Of Visceral Leishmaniasis.
Inventors include Bose Dasgupta, Dr. Somdeb; and Das, Dr. Payel.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: UNILAMELLAR LIPOSOMAL FORMULATION OF NORCLOMIPRAMINE FOR TREATMENT OF VISCERAL LEISHMANIASIS The present invention provides a unilamellar liposomal formulation of norclomipramine, an active metabolite of clomipramine, for the treatment of visceral leishmaniasis. The formulation comprises norclomipramine encap...